1. Liquid Chromatography‐Mass Spectrometry‐Based Plasma Metabolomics Study of the Effects of Moxibustion with Seed‐Sized Moxa Cone on Hyperlipidemia
   Qinghua Shao et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
2. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
   Qiliang Peng et al, 2017, Oncotarget CrossRef
3. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method
   María Gallardo-Gómez et al, 2021, Expert Review of Anticancer Therapy CrossRef
4. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity
   Sumadee De Silva et al, 2021, OncoTargets and Therapy CrossRef
5. AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review)
   Yarely Salinas‑Vera et al, 2018, International Journal of Molecular Medicine CrossRef
6. Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer
   Gang Li et al, 2020, Revista Española de Enfermedades Digestivas CrossRef
7. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios
   Nicola Normanno et al, 2018, Cancer Treatment Reviews CrossRef
8. Diagnostic value of circulating miR-21: An update meta-analysis in various cancers and validation in endometrial cancer
   Yun Gao et al, 2016, Oncotarget CrossRef
9. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis
   Tong Liu et al, 2021, Annals of Medicine CrossRef
10. Seminar: Extracellular Vesicles as Mediators of Environmental Stress in Human Disease
    Vrinda Kalia et al, 2023, Environmental Health Perspectives CrossRef
11. Circulating cell-free microRNAs as clinical cancer biomarkers
    Virginie Armand-Labit et al, 2017, Biomolecular Concepts CrossRef
12. Current Utility and Future Applications of ctDNA in Colorectal Cancer
    Daphne Day et al, 2019, Advances in the Molecular Understanding of Colorectal Cancer CrossRef
13. MicroRNAs for Diagnosis and Treatment of Colorectal Cancer
    Haitao Mei et al, 2021, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
14. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta‐analysis
    Chiman Mohammadi et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
15. The Roadmap of Colorectal Cancer Screening
    Enea Ferlizza et al, 2021, Cancers CrossRef
16. Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
    Susana Ourô et al, 2020, Frontiers in Oncology CrossRef
17. MicroRNAs as Biomarkers in Colorectal Cancer
    Takaaki Masuda et al, 2017, Cancers CrossRef
18. Methods and novel technology for microRNA quantification in colorectal cancer screening
    Laura Moody et al, 2017, Clinical Epigenetics CrossRef
19. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer
    Mitsuo Tsukamoto et al, 2017, Oncology CrossRef
20. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods
    Hai‐Ning Liu et al, 2018, Cancer Science CrossRef
21. Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis
    Haochang Hu et al, 2018, Oncotarget CrossRef
22. Prognostic significance of miR‐21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection
    Jiandong Zhang et al, 2018, Journal of Cellular Biochemistry CrossRef
23. Diagnostic value of RASSF1A hypermethylation in colorectal cancer: a meta-analysis
    Haochang Hu et al, 2018, Pathology - Research and Practice CrossRef
24. Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer
    Susana Ourô et al, 2020, Pharmaceuticals CrossRef